Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma
Authors:
Open Access
- 7 May 2024
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 73 (7) , 1-23
Abstract
Neuroblastoma (NB) is the most common and deadliest extracranial solid tumor in children. Targeting tumor-associated macrophages (TAMs) is a strategy for attenuating tumor-promoting states. The crosstalk between cancer cells and TAMs plays a pivotal role in mediating tumor progression in NB. The overexpression of Hexokinase-3 (HK3), a pivotal enzyme in glucose metabolism, has been associated with poor prognosis in NB patients. Furthermore, it correlates with the infiltration of M2-like macrophages within NB tumors, indicating its significant involvement in tumor progression. Therefore, HK3 not only directly regulates the malignant biological behaviors of tumor cells, such as proliferation, migration, and invasion, but also recruits and polarizes M2-like macrophages through the PI3K/AKT-CXCL14 axis in neuroblastoma. The secretion of lactate and histone lactylation alterations within tumor cells accompanies this interaction. Additionally, elevated expression of HK3 in M2-TAMs was found at the same time. Modulating HK3 within M2-TAMs alters the biological behavior of tumor cells, as demonstrated by our in vitro studies. This study highlights the pivotal role of HK3 in the progression of NB malignancy and its intricate regulatory network with M2-TAMs. It establishes HK3 as a promising dual-functional biomarker and therapeutic target in combating neuroblastoma.Keywords
Funding Information
- Science and Technology Innovation Key R&D Program of Chongqing (CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013, CSTB2022TIAD-STX0013)
- he Project of Science and Technology Commission of Chongqing (No. 7000025, No. 7000025, No. 7000025, No. 7000025, No. 7000025, No. 7000025, No. 7000025, No. 7000025, No. 7000025, No. 7000025)
This publication has 48 references indexed in Scilit:
- Crosstalk between glucose metabolism, lactate production and immune response modulationCytokine & Growth Factor Reviews, 2022
- Prognostic impact of tumor size on patients with neuroblastoma in a SEER‐based studyCancer Medicine, 2022
- Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogrammingCell Metabolism, 2021
- Immunological landscape of Neuroblastoma and its clinical significanceCancer Treatment and Research Communications, 2021
- The multifarious roles of the chemokine CXCL14 in cancer progression and immune responsesMolecular Carcinogenesis, 2020
- HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non‐small cell lung cancerClinical and Translational Medicine, 2020
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic TargetsCancer Cell, 2019
- Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg EffectBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018
- Progress in tumor-associated macrophage (TAM)-targeted therapeuticsAdvanced Drug Delivery Reviews, 2017
- CAFs and TAMs: maestros of the tumour microenvironmentThe Journal of Pathology, 2016